Correction to: Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells
In this article, the spheroid image obtained after 15 days of treatment of Hep3B with Cabozantinib was incorrectly duplicated from that obtained after 12 days. The new Fig. 1B shows the correct spheroid image at 15 days. The replacement does not change the results or conclusions of Fig. 1B. The auth...
| Autores: | , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2024 |
| País: | España |
| Institución: | Universidad de Sevilla (US) |
| Repositorio: | idUS. Depósito de Investigación de la Universidad de Sevilla |
| OAI Identifier: | oai:idus.us.es:11441/178985 |
| Acceso en línea: | https://hdl.handle.net/11441/178985 https://doi.org/10.1038/s41419-020-2558-1 |
| Access Level: | acceso abierto |
| Palabra clave: | Hepatocellular-carcinoma cells Epithelial-mesenchymal transition Sorafeni Regorafenib Cabozantinib |
| Sumario: | In this article, the spheroid image obtained after 15 days of treatment of Hep3B with Cabozantinib was incorrectly duplicated from that obtained after 12 days. The new Fig. 1B shows the correct spheroid image at 15 days. The replacement does not change the results or conclusions of Fig. 1B. The authors apologize for the unexpected error in the preparation of Fig. 1B. (excerpt) |
|---|